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Abstract. 
 
Attachment of many cell types to extracellu-
lar matrix proteins triggers cell spreading, a process
that strengthens cell adhesion and is a prerequisite for
 
many adhesion-dependent processes including cell
migration, survival, and proliferation. Cell spreading
 
requires integrins with intact 
 
b
 
 cytoplasmic domains,
presumably to connect integrins with the actin cytoskel-
eton and to activate signaling pathways that promote
cell spreading. Several signaling proteins are known to
regulate cell spreading, including R-Ras, PI 3-kinase,
PKC
 
e
 
 and Rac1; however, it is not known whether they
do so through a mechanism involving integrin 
 
b
 
 cyto-
plasmic domains. To study the mechanisms whereby
cell spreading is regulated by integrin 
 
b
 
 cytoplasmic do-
mains, we inhibited cell spreading on collagen I or ﬁ-
brinogen by expressing tac-
 
b
 
1, a dominant-negative in-
hibitor of integrin function, and examined whether cell
spreading could be restored by the coexpression of ei-
ther V38R-Ras, p110
 
a
 
-CAAX, myr-PKC
 
e
 
, or L61Rac1.
Each of these activated signaling proteins was able to
restore cell spreading as assayed by an increase in the
area of cells expressing tac-
 
b
 
1. R-Ras and Rac1 rescued
cell spreading in a GTP-dependent manner, whereas
PKC
 
e
 
 required an intact kinase domain. Importantly,
each of these signaling proteins required intact 
 
b
 
 cyto-
 
plasmic domains on the integrins mediating adhesion
in order to restore cell spreading. In addition, the res-
cue of cell spreading by V38R-Ras was inhibited by
LY294002, suggesting that PI 3-kinase activity is re-
quired for V38R-Ras to restore cell spreading. In con-
trast, L61Rac1 and myr-PKC
 
e
 
 each increased cell
spreading independent of PI 3-kinase activity. Ad-
ditionally, the dominant-negative mutant of Rac1,
N17Rac1, abrogated cell spreading and inhibited the
 
ability of p110
 
a
 
-CAAX and myr-PKC
 
e
 
 to increase
 
cell spreading. These studies suggest that R-Ras, PI
3-kinase, Rac1 and PKC
 
e
 
 require the function of inte-
grin 
 
b
 
 cytoplasmic domains to regulate cell spreading
and that Rac1 is downstream of PI 3-kinase and PKC
 
e
 
in a pathway involving integrin 
 
b
 
 cytoplasmic domain
function in cell spreading.
Key words: cell spreading • integrin • signaling •
Rac1 • R-Ras
 
Introduction
 
Integrins are a family of 
 
a
 
/
 
b
 
 heterodimeric transmem-
brane receptors used by cells to interact with their extra-
cellular matrix (Hynes, 1992). Integrins form a structural
link between the extracellular matrix and the cell’s cyto-
skeletal and signal transduction apparatus. Integrin engage-
ment triggers a myriad of intracellular signals resulting in
 
changes in intracellular pH and [Ca
 
2
 
1
 
], as well as the acti-
vation of protein kinases, phosphoinositide kinases, phos-
pholipases, and small GTP binding proteins (Schwartz et
al., 1995; Yamada and Miyamoto, 1995; Burridge and Chr-
zanowska-Wodnicka, 1996; LaFlamme et al., 1997). Many
of the signals activated by integrin engagement regulate
the adhesion process itself (Schwartz et al., 1995; Yamada
and Miyamoto, 1995; Burridge and Chrzanowska-Wod-
nicka, 1996; LaFlamme et al., 1997).
Cell spreading requires actin polymerization and reorga-
nization, the extension of lamellipodia or filopodia, and
the formation of new integrin-substrate adhesions (Small
et al., 1999). The initial interaction of integrins with their
ligand in cell attachment is believed to trigger signaling
 
pathways that regulate the process of cell spreading. PI
3-kinase has been shown to be activated by integrin-medi-
ated cell adhesion, and in some cell types PI 3-kinase activ-
ity is required for cell spreading (Khwaja et al., 1997; King
et al., 1997). The expression of an activated form of R-Ras
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(V38R-Ras) has also been shown to positively regulate cell
spreading, whereas the expression of dominant negative
R-Ras (N43R-Ras) can inhibit cell spreading in CHO cells
(Zhang et al., 1996). In addition, both PKC
 
a
 
 and PKC
 
e
 
 ap-
pear to be positive regulators of cell adhesion (Vuori and
Ruoslahti, 1993; Chun et al., 1996). PKC
 
e
 
 has been shown
to become activated upon cell attachment before spread-
ing and pharmacological inhibitors of PKC have been
shown to inhibit the process of spreading (Vuori and Ruo-
slahti, 1993; Chun et al., 1996). The small GTP binding pro-
teins Rac1 and Cdc42 are also regulators of cell spreading.
Integrin-mediated cell adhesion can trigger Rac1 activa-
tion (Del Pozo et al., 2000), and expression of dominant
negative mutants of Rac1 and Cdc42 have been shown to
inhibit cell spreading (Clark et al., 1998; Price et al., 1998;
Van Leeuwen et al., 1999). In addition to the requirement
for the activities of several signaling proteins, the process
of cell spreading is dependent upon intact 
 
b
 
 subunit cyto-
plasmic domains on the integrins mediating adhesion
(Ylanne et al., 1993); however, the molecular mechanisms
by which integrins and various signaling proteins regulate
cell spreading are not fully defined.
We and others have previously shown that expression of
isolated 
 
b
 
 cytoplasmic domains connected to the extracel-
lular and transmembrane domains of the small nonsignal-
ing (tac) subunit of the interleukin-2 receptor or other
extracellular reporters can inhibit endogenous integrin
function in a variety of cellular processes, including cell
spreading (Chen et al., 1994; LaFlamme et al., 1994; Luka-
shev et al., 1994; Smilenov et al., 1994). Recently, we have
shown that high levels of expression of the tac-
 
b
 
1 chimera
can inhibit both cell attachment to fibronectin and 
 
b
 
1 inte-
grin conformations that are favorable to 
 
b
 
1 integrin–
ligand interactions (Mastrangelo et al., 1999a). Since cells
expressing moderate levels of tac-
 
b
 
1 can attach, but are in-
hibited in cell spreading (LaFlamme et al., 1994; Mas-
trangelo et al., 1999a), we have used this system to study
the molecular mechanisms that regulate the process of cell
spreading. In this study, we asked whether activated forms
of signaling proteins known to positively regulate cell
spreading could restore cell spreading inhibited by the ex-
pression of tac-
 
b
 
1. We found that activated forms of PI
3-kinase, R-Ras, Rac1, and PKC
 
e
 
 could all restore cell
spreading inhibited by tac-
 
b
 
1 in both normal human fibro-
blasts adherent to collagen I and CHO cells expressing re-
combinant 
 
a
 
IIb
 
b
 
3 adherent to fibrinogen. Using CHO
cells expressing either wild-type recombinant
 
 
 
a
 
IIb
 
b
 
3 or
 
a
 
IIb
 
b
 
3 with a 
 
b
 
3 cytoplasmic domain truncation (
 
a
 
IIb
 
b
 
3
 
D
 
728), we show that the ability of V38R-Ras, L61Rac1,
p110
 
a
 
-CAAX, and myr-PKC
 
e
 
 to increase cell spreading in
tac-
 
b
 
1–expressing cells is dependent upon the presence of
intact 
 
b
 
 cytoplasmic domains on the integrins mediating
adhesion.
 
Materials and Methods
 
Antibodies and Matrix Proteins
 
Tac expression was monitored with FITC-conjugated antibodies to CD25
from Accurate Chemicals and Scientific Corp. and Becton Dickinson. Rab-
bit and goat polyclonal antibodies to the Myc (9E10) epitope, Flag epitope,
and PKC
 
e
 
 were purchased from Santa Cruz Biotechnology, Inc.
Rhodamine-conjugated goat antibodies to rabbit IgG were purchased from
 
Roche Molecular Biochemicals and Pierce. Rhodamine-conjugated donkey
antibodies to goat IgG were provided by Santa Cruz Biotechnology, Inc.
The 
 
b
 
1 integrin function blocking P4C10 ascites was purchased from
GIBCO-BRL and the control ascites from Sigma-Aldrich. The matrix pro-
teins collagen I (Vitrogen 100) and human fibrinogen were purchased from
Collagen Biomaterials and Enzyme Research Laboratories, respectively.
 
cDNAs, Cells, Transfections, and Spreading Assays
 
The eukaryotic expression vectors have been described previously: V38R-
Ras and N43R-Ras by Marte et al. (1996), p110
 
a
 
-CAAX by Wennstrom
and Downward (1999), and tac and tac-
 
b
 
1 by LaFlamme et al. (1992). Eu-
karyotic expression vectors for L61Rac1 and N17Rac1 were generously
provided by Dr. Alan Hall (University College, London, UK) and were
described previously by Lamarche et al. (1996). Myr-PKC
 
e
 
, PKC
 
e
 
, and
W437PKC
 
e
 
 were generous gifts from Dr. Alex Toker (Deaconess Medical
Center, Boston, MA) and were constructed similarly to the PKC
 
z
 
 con-
structs as previously described (Chou et al., 1998).
Primary human foreskin fibroblasts (Vec Technologies) were maintained
in DMEM supplemented with 10% fetal bovine serum and 2 mM 
 
L
 
-glu-
tamine. The stable CHO cell lines A5 (
 
a
 
IIb
 
b
 
3) and ETC12 (
 
a
 
IIb
 
b
 
3
 
D
 
728)
(Ylanne et al., 1995) were maintained in DMEM supplemented with 10%
fetal bovine serum, 2 mM 
 
L
 
-glutamine, and MEM nonessential amino acids.
Cells were transfected by electroporation (Mastrangelo et al., 1999b) with
20 
 
m
 
g of tac or tac-
 
b
 
1 expression vectors together with 40 
 
m
 
g of expression
vector for the various signaling proteins. For the kinase-dead PKC
 
e
 
 experi-
ment, comparable expression of the PKC
 
e
 
 proteins was observed by immu-
nofluorescence when 30 
 
m
 
g of PKC
 
e
 
 and 60 
 
m
 
g of kinase-dead W437PKC
 
e
 
expression vectors were transfected. For spreading assays, human fibro-
blasts were harvested by trypsinization with cold PBS 
 
z
 
16 h after elec-
troporation and were allowed to recover for 40 min at 37
 
8
 
C in suspension.
Approximately 4 
 
3 
 
10
 
5
 
 cells were plated onto glass coverslips coated with
20 
 
m
 
g/ml collagen I and were allowed to spread for 1 h at 37
 
8
 
C in serum-free
medium. Spreading assays using A5 and ETC12 CHO cell lines were per-
formed similarly; however, cells were allowed to recover for 1 h before plat-
ing onto glass coverslips coated with 15 
 
m
 
g/ml fibrinogen, and spreading was
assayed after 30 min (Ylanne et al., 1995). To determine whether cell
spreading on collagen I was dependent on endogenous 
 
b
 
1 integrins, the 
 
b
 
1
function blocking P4C10 ascites (1:1,000 dilution) or control ascites (1:1,000
dilution) was added 10 min after plating, at which time 
 
.
 
90% of the cells
had attached, but not spread. To determine the requirement for PI 3-kinase
activity, transiently transfected cells were incubated for 40 min in suspen-
sion with LY294002 (Calbiochem) at a final concentration of 50 
 
m
 
M, and
subsequently analyzed for spreading as described above.
 
Immunofluorescence and Quantification of Cell Area 
and Fluorescence Intensity
 
Adherent cells were fixed and processed for immunofluorescence as pre-
viously described (LaFlamme et al., 1992). Cells were stained for cell sur-
face expression of the tac epitope with FITC-conjugated antibodies to
CD25 before permeabilization. Cells cotransfected with R-Ras, Rac1, and
myr-PKC
 
e
 
 signaling proteins were subsequently permeabilized with PBS
containing 0.4% Triton X-100 for 5 min at room temperature, incubated
with rabbit polyclonal antibodies to the epitope tag of the signaling pro-
teins, and then with rhodamine-conjugated secondary antibodies. Cells
cotransfected with wild-type PKC
 
e
 
 and kinase-dead W437PKC
 
e
 
 were per-
meabilized with PBS containing 0.1% Triton X-100 and 3.7% formalde-
hyde for 15 min at room temperature and stained as described previously.
Microscopy was performed using an Olympus BX60 microscope equipped
with phase contrast and epifluorescence and attached to a Spot low light
camera interfaced with a PC computer (Diagnostic Instruments). Spot
software was used to acquire the fluorescence and interference reflection
microscopy (Izzard and Lochner, 1976) images of transfected cells. Cell
area and fluorescence intensity were measured using Image Pro-Plus soft-
ware (Media Cybernetics). Image Pro-Plus software was calibrated with
an Applied Micro Stage micrometer (Applied Image, Inc.). The accuracy
of the area measurements was confirmed with a TSM measurement slide
that contains etched squares of known dimensions. Preliminary studies in-
dicated that cells that are round and have not begun to spread have cell ar-
eas 
 
,
 
560 
 
m
 
m
 
2
 
. Hence, we define those cells with areas 
 
.
 
560 
 
m
 
m
 
2
 
 as
spread and cells with areas 
 
,
 
560 
 
m
 
m
 
2
 
 as not spread. The conditions used
to acquire the fluorescence images minimized the influence of cell shape;
however, for very small cells (areas 
 
,
 
320 
 
m
 
m
 
2
 
), our analysis may underes-
timate the expression level of recombinant proteins. 
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Results
 
Activated V38R-Ras, myr-PKC
 
e
 
, L61Rac1, or
p110
 
a
 
-CAAX Increase the Spreading of Cells 
Expressing Tac-
 
b
 
1
 
Previous studies have shown that the expression of tac-
 
b
 
1
can inhibit cell spreading on a variety of extracellular ma-
trix proteins (LaFlamme et al., 1994). In the present study,
we tested whether the expression of activated forms of sig-
naling proteins known to positively regulate cell spreading
could restore tac-
 
b
 
1–inhibited spreading. Normal fibro-
blasts were transiently transfected with tac-
 
b
 
1 or the con-
trol tac receptor alone, or cotransfected with tac-
 
b
 
1 and ei-
ther activated R-Ras, PKC
 
e
 
, Rac1, or PI 3-kinase.
Transfected cells were plated onto collagen I and allowed
to spread for 1 h. The cells adherent to collagen I were im-
munostained for tac expression and the expression of the
cotransfected signaling protein where appropriate. Cell
area and fluorescence intensity were quantified for posi-
tive and double positive cells using Image Pro-Plus soft-
ware as described in Materials and Methods.
In agreement with previous studies (LaFlamme et al.,
1994), we found that the majority of the tac-
 
b
 
1 positive
cells had cell areas 
 
,
 
560 
 
m
 
m
 
2
 
, indicating that they were in-
hibited in cell spreading (Fig. 1 B). In contrast, the major-
ity of cells expressing the control tac receptor had cell ar-
eas 
 
.
 
560 
 
m
 
m2, indicating that they were not inhibited in
spreading (Fig. 1 B). When we tested the ability of acti-
vated R-Ras (V38R-Ras) and membrane-anchored PKCe
(myr-PKCe) to restore tac-b1–inhibited cell spreading, we
found that the coexpression of tac-b1 with either V38R-
Ras or myr-PKCe resulted in an increase in cell area as
compared with cells expressing tac-b1 alone (Fig. 1 B).
Quantitation of the spreading assay revealed that 35% of
cells coexpressing myr-PKCe and 52% of cells coexpress-
ing V38R-Ras were spread, compared with 12% of cells
expressing tac-b1 alone. Coexpression of constitutively ac-
tive Rac1 (L61Rac1) also increased spreading of tac-b1–
expressing cells (Fig. 1 C). Of the cells coexpressing tac-b1
and L61Rac1, 86% were spread, compared with 13% ex-
pressing tac-b1 alone. Cotransfection of the membrane-
anchored catalytic subunit of PI 3-kinase also increased
the area of tac-b1–expressing cells (Fig. 1 D). When we
quantitated the spreading of cells cotransfected with tac-
b1 and p110a-CAAX as a function of tac epitope expres-
expression. The x axis is a linear scale of cell area from 0 to 2,400
mm2 and the y axis is a linear scale of FITC fluorescence (tac epitope
expression) from 0 to 3.2 3 104 (a) or 0 to 1.6 3 104 (b and c). (B–D)
The vertical line positioned at a cell area of 560 mm2 indicates the
separation of spread (right) and not spread (left) cells. It is impor-
tant to note that our spreading assays primarily analyze cells ex-
pressing moderate to low levels of tac-b1, since cell attachment to
collagen I is inhibited by the expression of high levels of tac-b1 (data
not shown). This observation is consistent with our recent studies
showing that high levels of tac-b1 inhibit cell attachment to fibronec-
tin (Mastrangelo et al., 1999a). The range of FITC fluorescence rep-
resents the range of tac-b1 expression detected in the adherent
transfected cells. These experiments were performed three times
and similar results were obtained.
Figure 1. Coexpression of either myr-PKCe, V38R-Ras, L61Rac1,
or p110a-CAAX with tac-b1 can restore cell spreading on collagen
I. (A) Diagram of the control tac receptor containing the extracellu-
lar and transmembrane domains of the small (tac) subunit of the hu-
man interleukin-2 receptor and the tac-b1 chimera containing the
same domains of the interleukin-2 receptor fused to the human inte-
grin b1A cytoplasmic domain. (B) Fibroblasts were transfected with
tac (a) or tac-b1 (b), or cotransfected with tac-b1 and myr-PKCe-
Flag (c and e) or tac-b1 and myc-V38R-Ras (d and f). Cell area for
100 randomly sampled positively transfected cells is plotted as a
function of either tac epitope expression (a–d), myr-PKCe-Flag ex-
pression (e) for the same cells shown in c, or myc-V38R-Ras expres-
sion (f) for the same cells shown in d. The x axis is a linear scale of
cell area from 0 to 1,600 mm2, the y axis is a linear scale of either
FITC fluorescence (tac epitope expression) units defined by Image
Pro-Plus from 0 to 2.4 3 104 (a–d) or rhodamine fluorescence (Flag
or myc epitope expression) from 0 to 1.2 3 105 (e and f). (C) Fibro-
blasts were transfected with tac (a) or tac-b1 (b), or cotransfected
with tac-b1 and myc-L61Rac1 (c and d). Cell area for 90 randomly
sampled cells expressing tac, tac-b1, or coexpressing tac-b1 and myc-
L61Rac1 is plotted as a function of tac epitope expression (a–c) or
myc epitope expression (d) for the cells shown in c. The x axis is a
linear scale of cell area from 0 to 2,400 mm2, the y axis is a linear
scale of FITC fluorescence (tac epitope expression) from 0 to 2.4 3
104 (a–c) or rhodamine fluorescence (myc epitope expression) from
0 to 1.2 3 105 (d). (D) Fibroblasts transfected with the control tac re-
ceptor (a) or tac-b1 (b) or tac-b1 and p110a-CAAX (c) were ana-
lyzed for cell-surface expression of the tac epitope and cell area, as
described in Materials and Methods. Cell area for 98 randomly sam-
pled positively transfected cells is plotted as a function of tac epitopeThe Journal of Cell Biology, Volume 151, 2000 1552
sion only (Fig. 1 D), we found that 59% of the tac-b1 and
p110a-CAAX cotransfected cells were spread compared
with only 9% of the cells transfected with tac-b1 alone. In
this instance, we were unable to quantitate p110a-CAAX
expression by immunofluorescence. However, we have
found in our assays that z80% of transfected cells coex-
press cotransfected plasmids (data not shown). Thus, as an
additional control, we analyzed the percentage of trans-
fected cells that spread as a function of tac epitope expres-
sion in four separate experiments and found that 57 6 9%
of the cells cotransfected with tac-b1 and p110a-CAAX
were spread compared with 12 6 5% of the cells trans-
fected with tac-b1 alone (quantitation is the mean 6 SD).
We also demonstrated that the rescue of cell spreading by
R-Ras, PI 3-kinase, PKCe, and Rac1 was dependent upon
their activation state or kinase activity. The rescue of cell
spreading by R-Ras and Rac1 was a GTP-dependent pro-
cess, since the coexpression of dominant-negative R-Ras
(N43R-Ras) or dominant-negative Rac1 (N17Rac1) failed
to increase the area of tac-b1–expressing cells (compare Fig.
2, g, i, and k). In addition, the kinase activities of PKCe and
PI 3-kinase were required to increase the cell area of tac-
b1–expressing cells, since the coexpression of kinase-dead
Figure 2. Coexpression of either N43R-Ras or N17Rac1 with tac-
b1 does not restore cell spreading on collagen I. Transiently
transfected cells were plated on collagen I and analyzed for cell
area (x axis) and expression of recombinant proteins (y axis):
cells transfected with tac (a) or tac-b1 alone (b) were analyzed
for cell area and tac epitope expression; cells cotransfected with
tac and myc-N43R-Ras were analyzed for cell area and tac (c) or
myc (d) epitope expression; cells cotransfected with tac and myc-
N17Rac1 were analyzed for cell area and tac (e) or myc (f)
epitope expression; cells cotransfected with tac-b1 and myc-
V38R-Ras were analyzed for cell area and tac (g) or myc (h)
epitope expression; cells cotransfected with tac-b1 and myc-
N43R-Ras were analyzed for cell area and tac epitope (i) or myc
(j) epitope expression; and cells cotransfected with tac-b1 and
myc-N17Rac1 were analyzed for cell area and tac (k) or myc (l)
epitope expression. In each instance, cell area and epitope ex-
pression was analyzed for 100 randomly sampled cells. The x axis
is a linear scale of cell area from 0 to 2.5 3 103 mm2. The y axis is
a linear scale of FITC fluorescence (tac epitope expression) from
0 to 105 (a, c, and e) and from 0 to 2.5 3 104 (b, g, i, and k), or
rhodamine fluorescence (myc epitope expression) from 0 to
8.0 3 104 (d, f, h, j, and l). The vertical line positioned at a cell
area of 560 mm2 indicates the separation of spread (right) and not
spread (left) cells. This experiment was performed twice and sim-
ilar results were observed.
Figure 3. The kinase activity of PKCe is required to increase the
spreading of cells coexpressing tac-b1. Transiently  transfected
cells were plated on collagen I and analyzed for cell area (x axis)
and expression of recombinant proteins (y axis): cells expressing
tac (a) or tac-b1 (b) were analyzed for cell area and tac epitope
expression; cells coexpressing tac and PKCe were analyzed for
cell area and tac (c) or PKCe (d) expression; cells coexpressing
tac and W437PKCe were analyzed for cell area and tac (e) or
PKCe (f) expression; cells coexpressing tac-b1 and PKCe were
analyzed for cell area and tac-b1 (g) or PKCe (h) expression; and
cells coexpressing tac-b1 and W437PKCe were analyzed for cell
area and tac-b1 (i) or PKCe (j) expression. In each instance, 100
randomly sampled positively transfected cells were analyzed. The
x axis is a linear scale of cell area from 0 to 4.0 3 103 mm2. The y
axis is a linear scale of FITC fluorescence (tac epitope expres-
sion) from 0 to 5.0 3 104 (a–c, e, g, and i), or rhodamine fluores-
cence (PKCe expression) from 0 to 3.0 3 105 (d, f, h, and j). The
vertical line positioned at a cell area of 560 mm2 indicates the sep-
aration of spread (right) and not spread (left) cells. This experi-
ment was performed twice and similar results were observed.Berrier et al. Rescue of Cell Spreading Inhibited by Tac-b1 1553
PKCe (W437PKCe) failed to rescue cell spreading and
LY294002 inhibited the ability of p110a-CAAX to restore
cell spreading (Fig. 3, g and i, and see Fig. 8 A).
We next examined the morphology of cells coexpressing
tac-b1 and each of the signaling proteins. As expected,
cells expressing tac had a normal fibroblast morphology,
whereas cells expressing tac-b1 were not spread (Fig. 4 A).
Cells expressing tac-b1 and either p110a-CAAX or myr-
PKCe were spread and had many membrane projections
(Fig. 4 A). In some instances, tac-b1 was observed in focal
adhesions of myr-PKCe–expressing cells (Fig. 4 B). The
morphology of cells coexpressing tac-b1 and either p110a-
CAAX or myr-PKCe was similar to many of the untrans-
fected cells or the cells expressing tac alone, indicating that
this is a common morphology for fibroblasts in our assay.
Many of the cells coexpressing tac-b1 and V38R-Ras ex-
hibited large polarized lamellipodia (Fig. 4 A) with promi-
nent focal adhesion staining of tac-b1 (Fig. 4 B). Cells co-
expressing tac-b1 and L61Rac1 were symmetrically spread
and exhibited membrane ruffling (Fig. 4 A) and tac-b1 lo-
calization in focal adhesions at the cell periphery (Fig. 4
B). Thus, expression of activated forms of PI 3-kinase,
PKCe, R-Ras, and Rac1 increased cell spreading through
distinct cell morphologies. Interestingly, cells expressing
L61Rac1 alone or V38R-Ras alone had cell morphologies
very similar to cells coexpressing tac-b1, which tended to
have smaller cell areas (Figs. 4 A and 5). Cells expressing
either myr-PKCe or p110a-CAAX alone had cell mor-
phologies similar to untransfected cells or cells transfected
with tac alone (Fig. 5).
We also examined the morphology of cells expressing
dominant-negative forms of Rac1 (N17Rac1) and R-Ras
(N43R-Ras). Expression of N17Rac1 resulted in cells that
were round and inhibited in cell spreading (Fig. 5). This is
in agreement with previously published observations by
others in different cell types (Clark et al., 1998; Price et al.,
1998). In contrast to N17Rac1, the expression of N43R-
Ras did not significantly affect cell morphology in our as-
say (Fig. 5). This observation differs from a previously
published report that N43R-Ras inhibits CHO cell spread-
ing (Zhang et al., 1996). Quantitation of the effect of ex-
pressing the kinase-dead or dominant-negative signaling
proteins on the extent of cell spreading confirmed our
morphological observations and indicated that the expres-
sion of kinase-dead PKCe did not significantly alter the ex-
tent of cell spreading (Figs. 2 and 3).
Although Cdc42 has also been suggested as a potential
regulator of cell spreading (Clark et al., 1998; Price et al.,
1998), we did not test the ability of activated Cdc42
(L61Cdc42) to rescue tac-b1–inhibited cell spreading. Ex-
pression of L61Cdc42 in normal human fibroblasts resulted
in cells with small areas, but which had prominent focal ad-
hesions and stress fibers (data not shown). Thus, scoring a
rescue of cell spreading by L61Cdc42 based on cell area
would have been difficult. However, expression of domi-
nant-negative Cdc42 (N17Cdc42) inhibited cell spreading
similar to the expression of N17Rac1 (data not shown).
Endogenous Integrin Extracellular and Cytoplasmic 
Domain Function Is Required for p110a-CAAX,
myr-PKCe, V38R-Ras, and L61Rac1 to Restore
Cell Spreading
To determine whether the rescue of cell spreading on col-
lagen I induced by the coexpression of activated signaling
proteins was a b1 integrin-dependent process, b1 function
blocking antibodies were added to the spreading assay af-
Figure 4. The morphology of cotransfected cells adherent to collagen I. (A) The morphology of cells expressing tac or tac-b1 alone or
cells coexpressing tac-b1 and either V38R-Ras, L61Rac1, or myr-PKCe. Shown is tac epitope expression (FITC fluorescence) for repre-
sentative cells from the quantitative experiment shown in Fig. 1. Also included is tac-b1 expression of a representative cell from the
cotransfection of tac-b1 and p110a-CAAX. Fluorescence images were obtained with Spot software and composites were generated in
adobe photoshop. Scale bar: 10 mm. (B) Coexpression of either V38R-Ras, L61Rac1, or myr-PKCe in addition to rescuing cell spread-
ing also restores the localization of tac-b1 to the focal contact. Fibroblasts were cotransfected with tac-b1 and either V38R-Ras,
L61Rac1, or myr-PKCe, and cells adherent to collagen were costained for tac and signaling protein expression as described previously.
The tac-FITC staining (right) and corresponding interference reflection pattern (left) of coexpressing cells is shown. Scale bar: 10 mm.The Journal of Cell Biology, Volume 151, 2000 1554
ter cell attachment had occurred, but before cell spread-
ing. Comparison of cell spreading of control and anti–b1-
treated cells indicated that fibroblast spreading on col-
lagen I and the rescue of spreading by these signaling
proteins were inhibited by the b1 blocking antibodies (Fig.
6). Thus, the rescue of cell spreading by V38R-Ras, myr-
PKCe, p110a-CAAX, and L61Rac1 is dependent upon the
extracellular function of endogenous b1 integrins. In the
case of cells coexpressing either R-Ras or Rac1, we also
examined the cell-surface expression of tac-b1 and the en-
dogenous b1 subunit. We found that the rescue of cell
spreading by constitutively active R-Ras and Rac1 did not
involve changes in the cell-surface expression of either tac-
b1 or the endogenous b1 subunit (data not shown).
We subsequently tested whether the ability of these sig-
naling proteins to restore cell spreading required intact in-
tegrin b cytoplasmic domains on the integrins mediating
cell adhesion. For these studies, we used CHO cells stably
expressing either wild-type recombinant aIIbb3 (A5 cells)
or aIIbb3D728 containing a b3 cytoplasmic domain trun-
cation (ETC12 cells) (Ylanne et al., 1993). Previous stud-
ies had demonstrated that A5 cells expressing wild-type
aIIbb3 spread on fibrinogen, whereas ETC12 cells ex-
pressing the b cytoplasmic domain truncation are inhib-
ited in cell spreading (Ylanne et al., 1993). Thus, if the ex-
pression of an activated signaling protein can induce cell
spreading independent of integrin b cytoplasmic domain
function, then this signaling protein should do so when ex-
pressed in ETC12 cells plated on fibrinogen.
A5 and ETC12 cells expressing the control tac receptor ex-
hibited differences in spreading on fibrinogen consistent with
the requirement for the b cytoplasmic domain in cell spread-
ing. The majority of A5 cells expressing the control tac recep-
tor had spread after 30 min, whereas the majority of the tac
expressing ETC12 cells had cell areas ,560 mm2 and were
not spread (Fig. 7, a and b). Both A5 and ETC12 cells ex-
pressing tac-b1 were inhibited in spreading with .97% of the
cells having cell areas ,560 mm2 (Fig. 7, c and d). Thus, ex-
pression of tac-b1 also inhibited CHO cell spreading on fi-
brinogen mediated by aIIbb3. V38R-Ras, p110a-CAAX,
myr-PKCe, and L61Rac1 were each able to restore CHO cell
spreading inhibited by tac-b1; however, this increase in cell
area was restricted to the A5 cells and was not observed in
ETC12 cells (Fig. 7). More than 30% of the A5 cells trans-
fected with tac-b1 and p110a-CAAX spread on fibrinogen,
whereas .98% of the ETC12 cells transfected with tac-b1
and p110a-CAAX were not spread (Fig. 7, e and f). Simi-
larly, comparison of the spreading of A5 and ETC12 cells ex-
pressing both tac-b1 and L61Rac1 revealed that none of the
ETC12 cells spread, whereas .15% of the A5 cells spread on
fibrinogen (Fig. 7, i and j). Finally, .40% of the A5 cells
transfected with tac-b1 and myr-PKCe spread on fibrinogen.
In contrast, .98% of the ETC12 cells transfected with tac-b1
and myr-PKCe were not spread and exhibited a round cell
morphology (Fig. 7, k and l). Thus, the enhancement of cell
spreading by V38R-Ras, p110a-CAAX, myr-PKCe, and
L61Rac1 requires intact b cytoplasmic domains on the inte-
grins mediating cell adhesion.
To ensure that the inability of signaling proteins to res-
cue ETC12 cell spreading on fibrinogen was due to the
lack of intact b3 cytoplasmic domains on the fibrinogen
binding integrins, and not to some peculiarity of the
ETC12 clone, we tested the ability of L61Rac1 and myr-
PKCe to restore tac-b1–inhibited ETC12 cell spreading on
fibronectin. Although ETC12 cells are not capable of
spreading on fibrinogen, they are able to spread on fi-
bronectin (Ylanne et al., 1995). We found that ETC12 cells
spread on fibronectin, and this spreading was inhibited by
tac-b1 and restored by the coexpression of either L61Rac1
or myr-PKCe (data not shown).
Figure 5. The morphology of
cells expressing either p110a-
CAAX, L61Rac1, N17Rac1,
V38R-Ras, N43R-Ras, or myr-
PKCe. Normal fibroblasts were
transfected with tac alone or
each of the signaling proteins,
and subsequently replated onto
collagen I as described in Materi-
als and Methods. Adherent cells
were immunostained for expres-
sion of the tac epitope in cells
transfected with the control tac
receptor alone or cotransfected
with the control tac receptor and
p110a-CAAX. Cells were immu-
nostained for expression of the
flag epitope in cells transfected
with myr-PKCe-Flag, or the myc
epitope in the case of myc-
L61Rac1, myc-N17Rac1, myc-
V38R-Ras, and myc-N43R-Ras.
Staining was visualized using
rhodamine-conjugated second-
ary antibodies. Fluorescence im-
ages were obtained as described
in Fig. 4. Scale bar: 10 mm.Berrier et al. Rescue of Cell Spreading Inhibited by Tac-b1 1555
V38R-Ras Requires PI 3-Kinase Activity to Rescue Cell 
Spreading, whereas L61Rac1 and myr-PKCe Do Not
R-Ras has been shown to activate PI 3-kinase (Marte et
al., 1996), suggesting that PI 3-kinase may be down-
stream of R-Ras in regulating cell spreading. In addi-
tion, PIP3, a product of PI 3-kinase, has been shown to
be involved in the activation of PKCe (Toker et al.,
1994; Moriya et al., 1996), suggesting that PI 3-kinase
may function upstream of PKCe activation during cell
spreading. PI 3-kinase activity has also been reported in
signaling pathways containing Rac1. Since PI 3-kinase
has been positioned both upstream and downstream of
Rac1 activation (Hawkins et al., 1995; Nobes et al.,
1995; Parker, 1995; Keely et al., 1997; Missy et al.,
1998), the role of PI 3-kinase in Rac1 signaling during
cell spreading is not certain.
To determine the requirement for PI 3-kinase activity in
the rescue of cell spreading by V38R-Ras, myr-PKCe, and
L61Rac1, the ability of cotransfected cells to spread on
collagen I was assayed in the presence and absence of the
PI 3-kinase inhibitor LY294002 (Fig. 8). Initial experi-
ments demonstrated a role for PI 3-kinase in normal fibro-
blast cell spreading. When fibroblasts transiently express-
ing the control tac receptor were assayed for their ability
to spread on collagen I in the presence of the PI 3-kinase
inhibitor (LY294002), .50% of the tac-expressing cells
were inhibited in spreading, compared with ,20% in the
presence of DMSO alone (Fig. 8, A, a and e, and B, a and
c). Thus, normal human fibroblasts require PI 3-kinase ac-
tivity for cell spreading on collagen I.
We then tested the ability of LY294002 to impair cell
spreading in cells cotransfected with tac-b1 and the vari-
ous constitutively activated signaling proteins. Greater
than 60% of cells cotransfected with tac-b1 and p110a-
CAAX spread in the presence of DMSO, whereas, in the
presence of LY294002, ,15% of these transfected cells
had areas .560 mm2, suggesting that p110a-CAAX re-
quires PI 3-kinase activity to enhance cell spreading (Fig.
8 A, b and f). The V38R-Ras–triggered rescue was also
found to require PI 3-kinase activity: .80% of the
cotransfected cells treated with LY294002 were not
spread (Fig. 8 B, b and d), compared with 44% of
cotransfected cells treated with DMSO. In contrast, cells
coexpressing tac-b1 and L61Rac1 were spread when
treated with either LY294002 or DMSO alone. Of the
cells coexpressing tac-b1 and L61Rac1, 78% were spread
when treated with DMSO and 63% were spread when
treated with LY294002 (Fig. 8 A, c and g). This was also
true for cells coexpressing tac-b1 and myr-PKCe. In cells
coexpressing tac-b1 and myr-PKCe, 60% of the DMSO-
treated cells and 45% of the LY294002-treated cells were
spread (Fig. 8 A, d and h). These results suggest that en-
dogenous PI 3-kinase activity is required for V38R-Ras,
but not for L61Rac1 or myr-PKCe, to restore cell spread-
ing in tac-b1–expressing cells.
Figure 6. The rescue of tac-b1–
inhibited cell spreading on col-
lagen I is a  b1 integrin–depen-
dent process. Human fibroblasts
transfected with the control tac
receptor alone (A, a and e, and
B, a and c) or cotransfected with
tac-b1 and either p110a-CAAX
(A, b and f), myr-PKCe (A, c and
g), V38R-Ras (A, d and h), or
L61Rac1 (B, b and d) were ana-
lyzed for spreading on collagen I
in the presence of control ascites
(A, a–d, and B, a and b) or b1
function blocking P4C10 ascites
(A, e–h, and B, c and d) as de-
scribed in Materials and Meth-
ods. The extent of cell spreading
and the expression levels of the
tac epitope were quantified for
100 (A) or 80 (B) randomly sam-
pled positively transfected cells,
and the results are shown by dot
plot. The x axis is a linear scale of
cell area from 0 to 3.2 3 103 mm2
(A and B). The y axis is a linear
scale of FITC fluorescence (tac
epitope expression) from 0 to
2.4  3  104 (A and B). The vertical
line positioned at a cell area of
560 mm2 indicates the separation
of spread (right) and not spread
(left) cells. These experiments
were performed twice and simi-
lar results were obtained.The Journal of Cell Biology, Volume 151, 2000 1556
Dominant-Negative N17Rac1 Blocks the p110a-CAAX 
and myr-PKCe Rescue of Cell Spreading
Both L61Rac1 and myr-PKCe rescued tac-b1–inhibited cell
spreading independent of PI 3-kinase activity, suggesting
that PKCe and Rac1 may function downstream of PI 3-ki-
nase in the rescue of cell spreading. To determine whether
PI 3-kinase and PKCe require Rac1 activity, we tested the
ability of p110a-CAAX and myr-PKCe to restore spread-
ing in cells expressing dominant-negative Rac1 (N17Rac1).
Fibroblasts were cotransfected with tac-b1 and either
p110a-CAAX or myr-PKCe together with N17Rac1, and
the extent of cell spreading was examined. Expression of
N17Rac1 inhibited cell spreading in all cases tested (Table
I). Greater than 90% of cells that coexpressed N17Rac1,
tac-b1, and either myr-PKCe or p110a-CAAX were round
and inhibited in cell spreading (Table I), indicating that
dominant-negative N17Rac1 blocks the ability of both myr-
PKCe and p110a-CAAX to rescue cell spreading. These
results suggest that Rac1 may function downstream of
PKCe  and PI 3-kinase in a pathway requiring integrin b cy-
toplasmic domain function in cell spreading.
Discussion
Cell spreading is a fundamental cellular process in many
cell types, which is initiated by integrin-mediated cell at-
tachment and requires integrin b subunit cytoplasmic do-
main function. Although the activation of R-Ras, PI
3-kinase, Rac1, and PKCe has been shown to positively
regulate cell spreading (Chun et al., 1996; Zhang et al.,
1996; King et al., 1997; Khwaja et al., 1997; Clark et al.,
1998; Price et al., 1998), the molecular mechanisms in-
volved for the most part remain undefined. In this study,
we asked whether the integrin b cytoplasmic domain is in-
volved in the regulation of cell spreading by these signaling
proteins. The experimental approach we used was to in-
hibit cell spreading by the expression of tac-b1, and then to
test whether the overexpression of activated forms of these
signaling proteins could overcome the inhibitory effect of
tac-b1. We found that inhibition of cell spreading by tac-b1
can be rescued by the coexpression of activated forms of ei-
ther R-Ras, PI 3-kinase, Rac1, or PKCe. The rescue of cell
spreading by each of these signaling proteins required en-
dogenous integrin extracellular domain function and intact
b subunit cytoplasmic domains on the adhering integrins.
The coexpression of each of these activated signaling pro-
teins with tac-b1 lead to significant increases in cell area.
Constitutively active R-Ras was by far the most potent at
reversing tac-b1–inhibited cell spreading. Coexpression of
Figure 7. The rescue of cell spreading by p110a-CAAX, V38R-
Ras, L61Rac1, and myr-PKCe is dependent upon integrin b cyto-
plasmic domains. Stable CHO cell lines A5 (left) and ETC12
(right) were each transfected with either tac (a and b) or tac-b1
alone (c and d) and the extent of cell spreading on fibrinogen was
analyzed. In addition, A5 (left) and ETC12 (right) cells were
cotransfected with tac-b1 and either p110a-CAAX (e and f),
V38R-Ras (g and h), L61Rac1 (i and j), or myr-PKCe (k and l)
and the extent of cell spreading on fibrinogen was analyzed. In
each case, 90 randomly sampled positively transfected cells ex-
pressing both tac-b1 and the signaling protein where appropriate
were analyzed for tac epitope expression and cell area. The data
are shown on the dot plots of tac epitope expression versus cell
area. The x axis is a linear scale of cell area from 0 to 1.6 3 103
mm2, and the y axis is a linear scale of FITC fluorescence (tac
epitope expression) from 0 to 4.8 3 104 (a and b) or 0 to 3.2 3 104
(c–l). These experiments were performed three times and similar
results were obtained.
Table I. N17Rac1 Blocks the p110a-CAAX and myr-PKCe 
Rescue of Cell Spreading
Transfected recombinant protein(s)
Percentage of
cells not spread*
Tac 1 Empty Vector 23 6 2‡
Tac 1 N17Rac1 94 6 4
Tac 1 N17Rac1 1 Empty Vector 91 6 5
Tac-b1 1 Empty Vector 57 6 14
Tac-b1 1 myr-PKCe 32 6 4
Tac-b1 1 myr-PKCe 1 Empty Vector  31 6 3
Tac-b1 1 myr-PKCe 1 N17Rac1§i 99 6 1
Tac-b1 1 myr-PKCe 1 N17Rac1§¶ 92 6 4
Tac-b1 1 p110a-CAAX 26 6 6
Tac-b1 1 p110a-CAAX 1 Empty Vector 26 6 2
Tac-b1 1 p110a-CAAX 1 N17Rac1i 91 6 4
*Morphology of transiently transfected normal fibroblasts plated onto a collagen I
substratum was analyzed. Transfected cells were identified by immunofluorescence
and scored by visual inspection for a spread or not spread phenotype. Over 100 trans-
fected cells were examined in each of four experiments. ‡The data is presented as the
mean percentage of cells scored as not spread 6 SD. §Although the majority of the
transfected cells in our assay coexpress each of the recombinant transfected proteins
(Homan et al., 1998), we were unable to detect the expression of three proteins simul-
taneously; therefore, we stained for two of the three transfected factors on parallel
coverslips originating from a pool of transfected cells. iSpreading assay analyzed for
double positive cells stained for tac-b1 and N17Rac1. ¶Spreading assay analyzed for
double positive cells stained for myr-PKCe and N17Rac1.Berrier et al. Rescue of Cell Spreading Inhibited by Tac-b1 1557
V38R-Ras resulted in cells with similar sizes and morpholo-
gies to untransfected or control tac-transfected cells. The
ability of V38R-Ras to rescue cell spreading was dependent
upon PI 3-kinase activity, which is consistent with previous
reports indicating that activated R-Ras can associate with
and activate PI 3-kinase (Marte et al., 1996). Thus, V38R-
Ras may rescue cell spreading by triggering pathways nor-
mally activated by integrins such as PI 3-kinase.
Interestingly, activated V38R-Ras has also been shown
to rescue high affinity ligand binding of aIIbb3 inhibited
by the constitutive activation of the ERK-MAPK cascade;
however, in this instance, R-Ras regulated integrin activity
by a pathway independent of PI 3-kinase (Sethi et al.,
1999). Thus, R-Ras may modulate integrin function via
multiple downstream effectors. Additionally, stable ex-
pression of activated R-Ras has been shown to activate
a2b1-dependent cell migration and invasion of carcinoma
cells by a mechanism requiring the a2 cytoplasmic domain,
suggesting that R-Ras might also specifically target indi-
vidual integrin heterodimers by regulating protein interac-
tions with their a subunit cytoplasmic domains (Keely et
al., 1999). However, the role of individual a subunit cyto-
plasmic domains in the rescue of cell spreading by V38R-
Ras is not known at present.
Little data has been published regarding how R-Ras is
activated under physiological conditions and there is cur-
rently no evidence linking integrin engagement to R-Ras
activation. Our result that expression of dominant-nega-
tive N43R-Ras does not inhibit cell spreading suggests that
integrin-triggered activation of R-Ras is not required for
spreading, at least in normal human fibroblasts. This result
contradicts earlier studies demonstrating that N43R-Ras
can inhibit CHO cell spreading (Zhang et al., 1996); how-
ever, the reason for these differences is not clear at this
time. Nonetheless, the ability of V38R-Ras to regulate cell
spreading in our system suggests that the activation of en-
dogenous R-Ras by signals initiated by other cell surface
receptors may regulate the spreading of some cell types.
Interestingly, although PI 3-kinase activity is required for
V38R-Ras to rescue tac-b1–inhibited cell spreading, the
membrane targeted form of PI 3-kinase, p110a-CAAX,
only partially restored cell spreading in tac-b1–expressing
cells compared with V38R-Ras. One possible explanation is
that V38R-Ras may lead to more robust PI 3-kinase signal-
ing compared with the expression of p110a-CAAX. Alter-
natively, V38R-Ras may activate additional pathways that
enhance cell spreading in conjunction with PI 3-kinase.
PI 3-kinase is known to be activated by integrin engage-
ment and was found to be important in normal fibroblast
cell spreading in the present study. The pathways linking
integrins to activation of PI 3-kinase are not yet fully de-
fined. The ability of integrins to activate FAK and H-Ras
provides two potential pathways, since both have been
shown to interact with and activate PI 3-kinase (Chen and
Guan, 1994; Kodaki et al., 1994; Rodriguez-Viciana et al.,
1994, 1996; Guan, 1997; Giancotti and Ruoslahti, 1999).
Figure 8. PI 3-kinase activity is required for V38R-Ras, but not for
L61Rac1 or myr-PKCe, to rescue cell spreading. Normal fibroblasts
were transfected with either tac alone (A, a and e, and B, a and c) or
cotransfected with tac-b1 and either V38R-Ras (B, b and d), p110a-
CAAX (A, b and f), L61Rac1 (A, c and g), or myr-PKCe (A, d and h),
and the morphology of cells adherent to collagen was analyzed in the
presence of the PI 3-kinase inhibitor, LY294002 (A, e–h, and B, c and
d), or DMSO (A, a–d, and B, c and d) as described in Materials and
Methods. In each case, 100 (A) or 95 (B) randomly sampled transfected
cells were analyzed for tac epitope expression and cell area as described
previously. The x axis is a linear scale of cell area from 0 to 2.4 3 103
mm2 (A) or 0 to 3.2 3 103 mm2 (B), and the y axis is a linear scale of
FITC fluorescence (tac epitope expression) from 0 to 4.8 3 104 (A, a
and e) or 0 to 2.4 3 104 (A, b–d and f–h, and B, b, d) or 0 to 8.0 3 104
(B, a and c). The vertical line positioned at 560 mm2 indicates the sepa-
ration of spread (right) and not spread (left) cells. These experiments
were performed three times and similar results were obtained.The Journal of Cell Biology, Volume 151, 2000 1558
However, the relative contribution of FAK and H-Ras to
integrin activation of PI 3-kinase is currently unknown.
Potential downstream effectors of PI 3-kinase in the regu-
lation of cell spreading are PKCe and Rac1 (Toker et al.,
1994; Moriya et al., 1996; Rodriguez-Viciana et al., 1997;
Missy et al., 1998). It is known that growth factor activa-
tion of PI 3-kinase can trigger membrane ruffling through
a Rac1-dependent pathway and roles for PI 3-kinase in the
activation of Rac1 have been described (Hawkins et al.,
1995; Nobes et al., 1995; Parker et al., 1995). Our observa-
tions that N17Rac1 prevents the ability of p110a-CAAX
to increase cell spreading and that L61Rac1 can restore
cell spreading independent of PI 3-kinase are consistent
with PI 3-kinase activation occurring either upstream or
independent of Rac1 in the regulation of cell spreading.
The rescue of cell spreading by myr-PKCe is also in-
dependent of PI 3-kinase, but inhibited by N17Rac1, simi-
larly suggesting that PKCe may reside downstream of PI
3-kinase and upstream of Rac1 in a pathway regulating
cell spreading.
The mechanism by which Rac1 regulates integrin-medi-
ated cell spreading is not completely understood. It is as-
sumed to do so by triggering actin polymerization and
membrane extension (lamellipodia) required for the in-
crease in cell area that accompanies cell spreading. We
have not yet identified signaling proteins that function
downstream of Rac1 to regulate cell spreading. PAK1,
which can be activated by Rac1, is a potential candidate
(Sells and Chernoff, 1997). Activated PAK1 mutants have
been shown to induce lamellipodia (Sells et al., 1997), and
dominant-negative mutants of PAK1 have been found to
inhibit cell spreading (Price et al., 1998). However,
whether PAK1 functions downstream of Rac1 in the in-
duction of lamellipodia is unclear since Rac1-induced
lamellipodia can occur independent of Rac1-PAK1 inter-
actions (Joneson et al., 1996; Lamarche et al., 1996;
Westwick et al., 1997).
POR1 is another potential downstream effector of Rac1
that may regulate cell spreading (Van Aelst et al., 1996).
POR1 has been shown to localize to lamellipodia and dom-
inant-negative forms of POR1 have been shown to inhibit
Rac1-induced lamellipodia (Van Aelst et al., 1996). In ad-
dition, mutations in Rac1 that inhibit Rac1-POR1 inter-
actions also inhibit lamellipodia formation (Joneson et
al., 1996), suggesting that POR1 is a good candidate.
P160Rock may also be a good candidate. P160Rock inter-
acts with Rac1 in a GTP-dependent manner (Lamarche et
al., 1996) and Rac1 mutations that inhibit p160Rock-Rac1
Figure 9. Models for the rescue
of tac-b1–inhibited cell spread-
ing. (a, Model I) Expression of
tac-b1 results in the titration of
cellular factors from the endoge-
nous b cytoplasmic domains that
trigger the activation of signal-
ing proteins required for cell
spreading. The coexpression of
activated recombinant signaling
proteins with tac-b1 may bypass
this block in integrin signaling
and restore cell spreading. Tac-
b1 does not inhibit integrin b cy-
toplasmic domain function that
is required downstream of these
signaling proteins. (b, Model II)
Integrin-mediated cell attach-
ment activates signaling proteins
that regulate the binding of pro-
teins to endogenous b cytoplas-
mic domains that are required
for cell spreading. Expression of
tac-b1 titrates these adhesion-
induced protein interactions
with the integrin b cytoplasmic
domains. Coexpression of acti-
vated signaling proteins with
tac-b1 increases the pool of pro-
teins that bind the integrin b cy-
toplasmic domain and restores
endogenous integrin function in
cell spreading. (Model III). Tac-
b1 inhibits the adhesion-induced
activation of these signaling pro-
teins and additionally inhibits
protein interactions with the b
cytoplasmic domain that are
triggered by the signaling pro-
teins (not shown).Berrier et al. Rescue of Cell Spreading Inhibited by Tac-b1 1559
interactions also inhibit lamellipodia formation (Lamarche
et al., 1996). Our future studies will determine whether
these effectors regulate integrin function in cell spreading.
We propose three models for the inhibition and rescue
of cell spreading. Our first model is that expression of tac-
b1 may inhibit cell spreading by titrating a b cytoplasmic
domain binding protein from endogenous integrin b cyto-
plasmic domains that may be required for the adhesion-
triggered activation of Rac1 (Fig. 9 a). Expression of acti-
vated Rac1 may bypass the block in integrin-triggered
Rac1 activation. However, even if this is the case, b cyto-
plasmic domain function is also required downstream
of Rac1 activation, since L61Rac1 could not rescue
the spreading of CHO cells attached to fibrinogen via
aIIbb3D728. So, in our first model, expression of tac-b1 in-
hibits the function of the b cytoplasmic domain upstream
but not downstream of Rac1 activation.
In our second model, we propose that Rac1 signaling
may regulate protein interactions with integrin b cytoplas-
mic domains that are required for cell spreading (Fig. 9 b).
In this model, integrin-induced Rac1 activation is not in-
hibited by the expression of tac-b1, instead tac-b1 inhibits
cell spreading by titrating these Rac1-induced integrin-
binding proteins from the endogenous integrin b cytoplas-
mic domains. Expression of L61Rac1 may rescue cell
spreading by increasing the cytoplasmic pool of proteins
that can bind to integrin b cytoplasmic domains. These in-
teractions may be required for Rac1 to initiate actin poly-
merization and lamellipodia formation. A third model is
also possible in which tac-b1 inhibits integrin activation of
Rac1 as well as the ability of Rac1 signaling to regulate in-
tegrin b cytoplasmic domain function. Future studies will
explore these possibilities.
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